From: Increased bronchiolitis burden and severity after the pandemic: a national multicentric study
Age at admission, days (mean ± SD) | Weight at birth, grams (mean ± SD) | Gestational age at birth, weeks (mean ± SD) | Comorbidities (n, %) all comorbidities; preterm, congenital heart disease, chronic lung illness, neuromuscular disease patients/immunodeficiencies | |
---|---|---|---|---|
2018–2019 N = 483 | 89 ± 74 | 3163 ± 649 | 38 ± 2.3 | 83 (17%); 52/22/8/1/0 |
2019–2020 N = 395 | 86 ± 75 | 3121 ± 613 | 38 ± 2.4 | 70 (18%); 43/13/13/0/1 |
2020–2021 N = 34 | 142 ± 114 | 2933 ± 902 | 38 ± 3.3 | 10 (29%); 4/2/4/0/0 |
2021–2022 N = 563 | 79 ± 74 | 3185 ± 630 | 38 ± 2.6 | 154 (27%); 51/35/14/4/1 |
2022–2023 N = 953 | 89 ± 78 | 3155 ± 617 | 38 ± 2.3 | 168 (18%); 109/43/13/3/0 |
p-value | p < 0.001 | p = 0.30 | p = 0.38 | p < 0.001 |